Intelligent Bio Solutions Inc.
INBS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001725430
No open-market purchases or sales by Intelligent Bio Solutions Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $416.2K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Intelligent Bio Solutions Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 14 | 8 | −6 |
| Shares | 597.5K | 315.5K | −282.0K (−47.2%) |
| Value | $2.52M | $605.8K | −$1.91M (−75.9%) |
New holders (2)
Institutions that held Intelligent Bio Solutions Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Altium Capital Management LP | 83,906 | $161.1K | 0.07% |
| Bank of America Corp | 25 | $48 | 0.00% |
Sold out (8)
Institutions that held Intelligent Bio Solutions Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Alyeska Investment Group, L.P. | 206,199 | $864.2K |
| Hudson Bay Capital Management LP | 108,250 | $456.8K |
| Citadel Advisors LLC | 14,842 | $62.6K |
| Virtu Financial LLC | 12,537 | $53.0K |
| Citigroup Inc | 7,960 | $33.6K |
| Headlands Technologies LLC | 26 | $110 |
| Wells Fargo & Company | 17 | $72 |
| JPMorgan Chase & Co | 4 | $17 |